Sandhya Raman
Verified
As seen in:
Bloomberg Law,
MSN,
Bloomberg News,
Chicago Tribune,
The Toronto Star,
Chron,
The Seattle Times,
Baltimore Sun,
Miami Herald,
Yahoo,
Pittsburgh Post-Gazette
and
Senior Healthcare Reporter for @BLAW sraman@bloombergindustry.com
Signal: sandhyawrites.30 // Talk to me about policy and paw-licy. 🏛️🐶
Articles by Sandhya Raman
Trump Names New Infectious Disease Director Leader Post-Fauci Original
The Trump administration selected John Powers III to lead the National Institute of Allergy and Infectious Diseases, an agency that came to prominence most recently during the pandemic under its longtime leader Anthony Fauci. Operating under the National Institutes of Health, the role is one of the most critical health positions not permanently filled in the last year.
Trump’s HHS Launches $25 Million Psychotropic Treatment Projects Original
The Trump administration announced a multimillion dollar effort Thursday to study the psychedelic drug ibogaine as a potential treatment for post-traumatic stress disorder, or PTSD. Proponents of ibogaine have hyped the drug as a possible game-changer for mental health treatment, but so far limited research has been done into the illegal drug and its safety. Health and Human Services Secretary Robert F.
CMS Seeks to Loosen Some Requirements for Providers, Suppliers Original
The Centers for Medicare & Medicaid Services issued a proposed rule Thursday intended to streamline regulations across thirteen areas including hospitals, long-term care facilities and payment transparency, and loosen some requirements related to Covid-19. CMS said the proposal (RIN 0938-AW04) would lift certain requirements for providers and suppliers that participate in the Medicare and Medicaid programs, and estimates if finalized would save the federal government about $320 million annually.
Fired Worker Sues HHS Alleging Discrimination, Retaliation Original
A former federal worker filed a lawsuit against the Department of Health and Human Services alleging he was wrongfully terminated. Dia Harris worked at HHS as chief equity officer for the Office of the Assistant Secretary for Children and Families and senior adviser to the Office of Community Services before he was put on leave and terminated.
Judge Dismisses Doctors’ Challenge to CDC’s Vaccine Guidelines
A federal judge dismissed a challenge to the Centers for Disease Control and Prevention’s pediatric immunization schedule for lack of standing on Friday. The decision is another legal blow for vaccine skeptics that have sought to reshape how the CDC and other agencies approach federal vaccine recommendations. The American Academy of Pediatrics’s challenge to Health Secretary Robert F.
Judge Dismisses Doctors’ Challenge to CDC’s Vaccine Guidelines
A federal judge dismissed a challenge to the Centers for Disease Control and Prevention’s pediatric immunization schedule for lack of standing on Friday. The decision is another legal blow for vaccine skeptics that have sought to reshape how the CDC and other agencies approach federal vaccine recommendations. The American Academy of Pediatrics’s challenge to Health Secretary Robert F.
Gender Dysphoria Dropped as Disability Under Trump HHS Rule Original
The Trump administration issued a infinal rule on Friday to narrow the definition of disability in federal health programs to exclude gender dysphoria. The policy change follows a series of moves by the Department of Health and Human Services and other agencies to restrict services and protections for transgender individuals.
Judge Dismisses Transgender Health Providers’ Suit Against FTC Original
A federal judge agreed to dismiss without prejudice the World Professional Association for Transgender Health’s lawsuit challenging an FTC probe into the group’s promotion of pediatric gender-affirming care. WPATH is one of three health professional groups that sued the FTC this year challenging federal investigations into their issuing of guidance and recommendations related to transgender health.
Officials Cite Ethics Issues for Research Agency Leader’s Leave Original
Officials at the Advanced Research Projects Agency for Health briefed staff Tuesday on the absence of their director, who is on leave as the Department of Health and Human Services resolves issues in the ethics clearance process. The HHS said Monday that ARPA-H Director Alicia Jackson is on administrative leave, following questions from Bloomberg Law about a limited conflict of interest waiver she sought for her role due to financial interests.
Health Research Agency Head on Administrative Leave, HHS Says
The director of the Advanced Research Projects Agency for Health, Alicia Jackson, is on administrative leave, according to a Department of Health and Human Services spokesperson. Jackson, a former health technology industry executive, was sworn in on Oct. 20, 2025 to lead the health research agency, which reports directly to the HHS Secretary. Her role as director includes setting priorities and awarding contracts to universities and biotech companies using the agency’s $1.5 billion annual budget.
Health Research Agency Director Goes on Administrative Leave (1)
The director of the Advanced Research Projects Agency for Health, Alicia Jackson, is on administrative leave, after seeking a conflict of interest waiver for the role due to financial interests. Jackson, a former health technology industry executive, was appointed by President Donald Trump and sworn in on Oct. 20, 2025 to lead the health research agency, which reports directly to the Health and Human Services Secretary.
Labor Watchdog Cautions HHS on Use of AI After Errors in Brief Original
A federal labor watchdog urged the Department of Health and Human Services to use caution in relying on AI, after discovering discrepancies in the majority of the agency’s citations in a recent brief.
Tougher Federal Worker Reviews Roll Out With Hits to Morale
|
The Trump administration is rolling out seismic changes to federal performance evaluations — and workers say they are already eroding morale and diminishing managers’ input. For the first time in decades, federal employees will be ranked among their peers rather than evaluated solely against performance standards. As part of that ranking, the new system caps the number of high reviews managers can award, but reserves larger bonuses for those top performers.
By Ian Kullgren, Skye Witley Verified, Evan Weinberger Verified, Sandhya Raman Verified, Lauren Clason Verified, Nino Paoli Verified
|
Bloomberg Tax
Verified
Tougher Federal Worker Reviews Roll Out With Hits to Morale
|
Deep Dive Oct. 20, 2026, 9:00 AM UTC The Trump administration is rolling out seismic changes to federal performance evaluations — and workers say they are already eroding morale and diminishing managers’ input. For the first time in decades, federal employees will be ranked among their peers rather than evaluated solely against performance standards. As part of that ranking, the new system caps the number of high reviews managers can award, but reserves larger bonuses for those top performers.
By Ian Kullgren, Skye Witley Verified, Evan Weinberger Verified, Sandhya Raman Verified, Lauren Clason Verified, Nino Paoli Verified
|
Bloomberg Government
Verified
NIH Weighs Grant Changes Critics Fear as Politicizing Process
The National Institutes of Health is considering feedback on its proposal to overhaul how the agency uses peer review in grant applications, a move some scientists say could lead to more politicization in the tens of billions of dollars the agency doles out annually.
NIH Weighs Grant Changes Critics Fear as Politicizing Process
The National Institutes of Health is considering feedback on its proposal to overhaul how the agency uses peer review in grant applications, a move some scientists say could lead to more politicization in the tens of billions of dollars the agency doles out annually.
RFK Jr. Escalates Pediatric Gender Care Tensions With Providers Original
Health and Human Services Secretary Robert F. Kennedy Jr. is ratcheting up pressure on six health professional organizations seeking clarity on their guidance and current policies promoting gender-affirming care for transgender minors. Kennedy framed the letters as a “final request” for updates on the groups’ policies in light of an HHS reporton gender ideology and other actions taken by the Trump administration this year.
RFK Jr. Vaccine Injury Plan Rebuked for Skewed Doctor Incentives
US Health Secretary Robert F. Kennedy Jr.'s proposal to pay doctors to collect information about vaccine injuries drew criticism from medical groups over concerns it would create perverse incentives and a perception of causality not based on evidence. The idea is one pillar of the Department of Health and Human Services’ new vaccine injury research project formally announced on Thursday, three days after agency leaders secretly met at the National Institutes of Health to pitch it.
RFK Jr. Vaccine Injury Plan Rebuked for Skewed Doctor Incentives
US Health Secretary Robert F. Kennedy Jr.'s proposal to pay doctors to collect information about vaccine injuries drew criticism from medical groups over concerns it would create perverse incentives and a perception of causality not based on evidence. The idea is one pillar of the Department of Health and Human Services’ new vaccine injury research project formally announced on Thursday, three days after agency leaders secretly met at the National Institutes of Health to pitch it.
Trump Punts Abortion Drug Review Until After Midterms (1)
The Trump administration intends to complete its safety review of an abortion drug by March 2027, government lawyers said in a court filing published late Wednesday, effectively punting it until after the midterm elections. The update from the Food and Drug Administration is a blow to anti-abortion groups and Republican lawmakers who pushed FDA leadership to conduct a speedy review. Polling finds a large majority of the public opposes restricting medication abortion.
Trump Punts Abortion Drug Review Until After Midterm Elections
The Trump administration intends to complete its safety review of an abortion drug by March 2027, government lawyers said in a court filing published late Wednesday. The update from the Food and Drug Administration confirms that any policy changes affecting mifepristone will not be released until after the midterm elections, a blow to anti-abortion groups and Republican lawmakers who pushed FDA leadership to conduct a speedy review.
Trump Punts Abortion Drug Review Until After Midterm Elections
The Trump administration intends to complete its safety review of an abortion drug by March 2027, government lawyers said in a court filing published late Wednesday.
Trump Punts Abortion Drug Review Until After Midterm Elections
Oct. 8, 2026, 1:11 PM UTC The Trump administration intends to complete its safety review of an abortion drug by March 2027, government lawyers said in a court filing published late Wednesday. The update from the Food and Drug Administration confirms that any policy changes affecting mifepristone will not be released until after the midterm elections, a blow to anti-abortion groups and Republican lawmakers who pushed FDA leadership to conduct a speedy review.
Trump Wrongfully Withheld Health Research Funds, Watchdog Finds
Oct. 7, 2026, 6:57 PM UTC The Trump administration violated spending law in withholding grant funds for the health quality research agency at the Department of Health and Human Services, a federal government watchdog agency found. The Government Accountability Office issued its findings on Wednesday, ahead of an expected update from the federal government in ongoing litigation over changes to the the Agency for Healthcare Research and Quality.
Trump Wrongfully Withheld Health Research Funds, Watchdog Finds
The Trump administration violated spending law in withholding grant funds for the health quality research agency at the Department of Health and Human Services, a federal government watchdog agency found.
HHS Seeks to Throw Out Havana Syndrome Lawsuit in Case Brief
Lawyers for the federal government said the court lacks jurisdiction to consider a lawsuit challenging its alleged lack of agency response on Havana Syndrome, a cluster of symptoms first documented at the US embassy in Cuba in 2016.
HHS Seeks to Throw Out Havana Syndrome Lawsuit in Case Brief
Lawyers for the federal government said the court lacks jurisdiction to consider a lawsuit challenging its alleged lack of agency response on Havana Syndrome, a cluster of symptoms first documented at the US embassy in Cuba in 2016.
RFK Jr. announces vaccine injury clinic, initiative at NIH
Health and Human Services Secretary Robert F. Kennedy Jr. announced a new research initiative at the National Institutes of Health to study vaccine injuries on Monday, according to people familiar with the matter. Kennedy visited the NIH campus in Bethesda, Maryland, to unveil the initiative, said the people, who weren’t authorized to discuss the event publicly.
RFK Jr. announces vaccine injury clinic, initiative at NIH
Health and Human Services Secretary Robert F. Kennedy Jr. announced a new research initiative at the National Institutes of Health to study vaccine injuries on Monday, according to people familiar with the matter. Kennedy visited the NIH campus in Bethesda, Maryland, to unveil the initiative, said the people, who weren’t authorized to discuss the event publicly.
RFK Jr. Announces Vaccine Injury Clinic, Initiative at NIH Original
Photographer: Finn Gomez/Getty Images (Bloomberg) -- Health and Human Services Secretary Robert F.
RFK Jr. to Announce New Vaccine Injury Research at NIH
Health and Human Services Secretary Robert F. Kennedy Jr. will announce a new research initiative at the National Institutes of Health to study vaccine injuries on Monday, according to people familiar with the matter.
Trump's Transgender Youth Medicaid Ban Challenged by Families
Four families sued the Trump Administration seeking to stop the implementation of a regulation that would block Medicaid from covering gender-affirming care to minors.
Trump’s Transgender Youth Medicaid Ban Challenged by Families
Four families sued the Trump Administration seeking to stop the implementation of a regulation that would block Medicaid from covering gender-affirming care to minors. The lawsuit, filed in the US District Court for the District of New Hampshire on Thursday, asks the court to stop the Centers for Medicare & Medicaid Services rule from taking effect Oct. 13.
Pfizer Sued By Florida AG Over its Covid-19 Vaccine Marketing
Florida Attorney General James Uthmeier filed a lawsuit against Pfizer Inc. alleging the drug company and its chief executive misled individuals about the safety of its Covid-19 vaccine.
Pfizer Sued By Florida AG Over Covid-19 Vaccine Marketing (1)
Florida Attorney General James Uthmeier filed a lawsuit against alleging the drug company and its chief executive misled individuals about the safety of its Covid-19 vaccine. The lawsuit, filed in the Circuit Court for the 19th Judicial Circuit, argues that Pfizer and CEO Albert Bourla, knowingly marketed the vaccine while concealing safety risks for pregnant women, known adverse effects, and the risk of myocarditis.
Lawmakers Warn Trump Administration Against Expiring Funding Original
Sept. 25, 2026, 9:00 AM UTC Lawmakers in both parties are telling the Trump administration not to use the waning days of the fiscal year to redirect federal funding from its intended purpose, or let money dry up entirely. Federal law requires the executive branch to spend the money lawmakers gave them before Sept. 30, when the government will close its books on the 2026 fiscal year.
Judge Extends Teen Pregnancy Fund Deadline Amid Legal Fight
Sept. 21, 2026, 9:15 PM UTC A federal judge granted an order preventing teen pregnancy prevention funding from lapsing while a lawsuit challenging Trump administration policy changes continues. Hennepin County, Minn., King County, Wash., Planned Parenthood of the Heartland, and the Sexuality Information and Education Council of the United States sued the Department of Health and Human Services’ over changes to and early termination of grants under the program earlier this year.
Family Planning Grant Change Dispute Dismissed by Federal Judge
Sept. 18, 2026, 9:36 PM UTC A federal judge dismissed a challenge on which types of organizations would be eligible to federal family planning funds. Judge Jennifer P. Wilson of the US District Court for the Middle District of Pennsylvania granted the federal government’s request to dismiss the amended complaint, without prejudice, from plaintiffs, the National Family Planning and Reproductive Health Association and the Family Health Council of Central Pennsylvania.
FTC, Clinician Group Agree to Settle Transgender Health Case
The Federal Trade Commission and the Endocrine Society agreed to dismiss without prejudice the medical group’s lawsuit challenging a government investigation into its activities and communications promoting pediatric gender-affirming care. The Endocrine Society is one of three health professional groups that sued the FTC this year seeking to halt civil investigative demands related to transgender health.
Trump’s NIH Grant Cuts Challenged in Proposed Class Action
Researchers filed a lawsuit on Wednesday against the National Institutes of Health, challenging the agency’s cuts to thousands of medical research grants based on the Trump administration’s political priorities. Seventeen prior recipients of NIH funding filed the suit on behalf of themselves and others similarly situated, seeking to represent two classes of researchers alleging violations of the First Amendment and Administrative Procedures Act.
Political Oversight of Grants Spreads as Congress Halts OMB Rule Original
Sept. 10, 2026, 9:00 AM UTC Agencies are moving to give political appointees a bigger say in how grant money goes out the door, even as Congress has stalled the White House’s efforts to expand such authorities across the federal government. An Office of Management and Budget proposal to curb spending it deems wasteful would require that senior appointees review discretionary awards, which in the past have been handled by career employees.
Abortion Drug Access Weighed in Louisiana Suit Versus FDA
A federal appeals court questioned both its authority to act and the FDA’s processes in a red-state challenge to the agency’s rules allowing mail-order dispensing of the abortion drug mifepristone. Louisiana is one of several GOP-led states seeking to roll back approval of the drug since the Supreme Court’s 2022 decision in Dobbs v. Jackson Women’s Health Organization overturning the federal right to an abortion.
Pentagon Is Redirecting NIH Research Funding, DeLauro Says Original
Sept. 3, 2026, 8:25 PM UTC The Department of Defense is attempting to redirect National Institute of Health money to bolster the Pentagon’s budget, according to the top Democrat on the House Appropriations Committee. Defense officials signed an interagency agreement that could divert billions of NIH funding meant for biomedical research to the Pentagon, House Appropriations ranking member Rosa DeLauro (D-Conn.) said in a statement Thursday.
NIH Seeks Input on Remaking Infectious Disease Agency Post-Fauci
Aug. 28, 2026, 2:58 PM UTC The National Institutes of Health is seeking public input in a move toward reorganizing infectious disease research — at the agency thrust into the spotlight during the pandemic. The National Institute of Allergy and Infectious Diseases issued a notice Friday that the NIH will accept comments on a proposed reorganization of NIAID’s research between Sept. 14-18, but provided few other details.
NIH Seeks Input on Remaking Infectious Disease Agency Post-Fauci
The National Institutes of Health is seeking public input in a move toward reorganizing infectious disease research — at the agency thrust into the spotlight during the pandemic. The National Institute of Allergy and Infectious Diseases issued a notice Friday that the NIH will accept comments on a proposed reorganization of NIAID’s research between Sept. 14-18, but provided few other details.
Autism Panel Moves Ahead With New Framework Despite Pushback
A federal advisory panel voted on Thursday in favor of a new blueprint for autism policy despite objections from patient advocacy groups over the abbreviated timeline and drafting process. The Health and Human Services Department’s Interagency Autism Coordinating Committee voted overwhelmingly to adopt a wide-ranging framework for 2026-2028 that recommends a federal path for funding, clinical research, social supports, and establishing a central Autism.gov website.
HHS Autism Panel Considers Shift from Genetics, Sparking Alarm
A recently overhauled federal advisory panel is set to consider a shift of resources for autism policy on Thursday, on the heels of the Trump administration’s renewed focus on an unproven link between vaccines and autism. The Health and Human Services Department’s Interagency Autism Coordinating Committee will meet for the second time this year after Health Secretary Robert F. Kennedy Jr. replaced the body’s 21 public members in January.
FTC, Pediatricians Group Agree to Settle Transgender Health Case
The Federal Trade Commission and the American Academy of Pediatrics agreed to settle without prejudice the AAP’s lawsuit against the agency’s investigation into the group’s communications and promotion of gender-affirming care Monday. The AAP sued the FTC in February over its civil investigative demand seeking details about the personnel involved and process of establishing clinical guidelines for pediatric gender dysphoria treatment.
RFK Jr. Moves Further Toward Loosening Federal Vaccine Advice
Health and Human Services Secretary Robert F. Kennedy Jr. took another step toward his promise to further loosen federal vaccine advice, seeking feedback on which vaccines should be recommended universally. President Donald Trump signed an executive order Aug. 10, dovetailing with several vaccine-related actions taken this month. The administration has publicly re-embraced efforts championed by vaccine skeptics that question their safety and broader requirements.
Trump’s Teen Pregnancy Grant Funding Limits Paused by Judge
Aug. 19, 2026, 5:50 PM UTC A federal judge temporarily paused the Trump administration’s limits to a grant program designed to limit teen pregnancy, but stopped short of reinstating terminated grants.
Show More
loading
Actions
Get in touch with Sandhya
Contact Sandhya, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack